Medical - Devices
Compare Stocks
2 / 10Stock Comparison
INGN vs LNTH
Revenue, margins, valuation, and 5-year total return — side by side.
Drug Manufacturers - Specialty & Generic
INGN vs LNTH — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Devices | Drug Manufacturers - Specialty & Generic |
| Market Cap | $193M | $5.61B |
| Revenue (TTM) | $349M | $1.54B |
| Net Income (TTM) | $-23M | $234M |
| Gross Margin | 47.6% | 61.1% |
| Operating Margin | -8.7% | 20.2% |
| Forward P/E | — | 16.6x |
| Total Debt | $17M | $738K |
| Cash & Equiv. | $104M | $359M |
INGN vs LNTH — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Inogen, Inc. (INGN) | 100 | 18.7 | -81.3% |
| Lantheus Holdings, … (LNTH) | 100 | 627.5 | +527.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: INGN vs LNTH
Each card shows where this stock fits in a portfolio — not just who wins on paper.
INGN is the clearest fit if your priority is growth exposure.
- Rev growth 3.9%, EPS growth 44.1%, 3Y rev CAGR -2.6%
- 3.9% revenue growth vs LNTH's 0.5%
- +0.6% vs LNTH's -17.8%
LNTH carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 0 yrs, beta 0.47
- 40.0% 10Y total return vs INGN's -85.3%
- Lower volatility, beta 0.47, Low D/E 0.1%, current ratio 2.70x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 3.9% revenue growth vs LNTH's 0.5% | |
| Quality / Margins | 15.2% margin vs INGN's -6.5% | |
| Stability / Safety | Beta 0.47 vs INGN's 1.10, lower leverage | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +0.6% vs LNTH's -17.8% | |
| Efficiency (ROA) | 10.8% ROA vs INGN's -7.6%, ROIC 30.6% vs -24.4% |
INGN vs LNTH — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
INGN vs LNTH — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
LNTH leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
LNTH is the larger business by revenue, generating $1.5B annually — 4.4x INGN's $349M. LNTH is the more profitable business, keeping 15.2% of every revenue dollar as net income compared to INGN's -6.5%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $349M | $1.5B |
| EBITDAEarnings before interest/tax | -$10M | $381M |
| Net IncomeAfter-tax profit | -$23M | $234M |
| Free Cash FlowCash after capex | -$21M | $349M |
| Gross MarginGross profit ÷ Revenue | +47.6% | +61.1% |
| Operating MarginEBIT ÷ Revenue | -8.7% | +20.2% |
| Net MarginNet income ÷ Revenue | -6.5% | +15.2% |
| FCF MarginFCF ÷ Revenue | -6.1% | +22.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.0% | +4.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +39.0% | +5.8% |
Valuation Metrics
INGN leads this category, winning 3 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $193M | $5.6B |
| Enterprise ValueMkt cap + debt − cash | $107M | $5.3B |
| Trailing P/EPrice ÷ TTM EPS | -8.36x | 25.26x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 16.59x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 13.78x |
| Price / SalesMarket cap ÷ Revenue | 0.55x | 3.64x |
| Price / BookPrice ÷ Book value/share | 1.01x | 5.41x |
| Price / FCFMarket cap ÷ FCF | — | 15.84x |
Profitability & Efficiency
LNTH leads this category, winning 7 of 8 comparable metrics.
Profitability & Efficiency
LNTH delivers a 20.6% return on equity — every $100 of shareholder capital generates $21 in annual profit, vs $-12 for INGN. LNTH carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to INGN's 0.09x. On the Piotroski fundamental quality scale (0–9), INGN scores 6/9 vs LNTH's 5/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -11.8% | +20.6% |
| ROA (TTM)Return on assets | -7.6% | +10.8% |
| ROICReturn on invested capital | -24.4% | +30.6% |
| ROCEReturn on capital employed | -13.3% | +17.1% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.09x | 0.00x |
| Net DebtTotal debt minus cash | -$86M | -$358M |
| Cash & Equiv.Liquid assets | $104M | $359M |
| Total DebtShort + long-term debt | $17M | $738,000 |
| Interest CoverageEBIT ÷ Interest expense | — | 16.89x |
Total Returns (Dividends Reinvested)
LNTH leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in LNTH five years ago would be worth $39,000 today (with dividends reinvested), compared to $1,077 for INGN. Over the past 12 months, INGN leads with a +0.6% total return vs LNTH's -17.8%. The 3-year compound annual growth rate (CAGR) favors LNTH at -3.1% vs INGN's -15.7% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +7.2% | +28.1% |
| 1-Year ReturnPast 12 months | +0.6% | -17.8% |
| 3-Year ReturnCumulative with dividends | -40.0% | -9.1% |
| 5-Year ReturnCumulative with dividends | -89.2% | +290.0% |
| 10-Year ReturnCumulative with dividends | -85.3% | +4002.4% |
| CAGR (3Y)Annualised 3-year return | -15.7% | -3.1% |
Risk & Volatility
LNTH leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
LNTH is the less volatile stock with a 0.47 beta — it tends to amplify market swings less than INGN's 1.10 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.10x | 0.47x |
| 52-Week HighHighest price in past year | $9.13 | $108.91 |
| 52-Week LowLowest price in past year | $5.34 | $47.25 |
| % of 52W HighCurrent price vs 52-week peak | +77.9% | +79.1% |
| RSI (14)Momentum oscillator 0–100 | 57.3 | 60.5 |
| Avg Volume (50D)Average daily shares traded | 295K | 878K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates INGN as "Buy" and LNTH as "Buy". Consensus price targets imply 265.7% upside for INGN (target: $26) vs 17.2% for LNTH (target: $101).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $26.00 | $101.00 |
| # AnalystsCovering analysts | 11 | 17 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 0 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +5.3% |
LNTH leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). INGN leads in 1 (Valuation Metrics).
INGN vs LNTH: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is INGN or LNTH a better buy right now?
For growth investors, Inogen, Inc.
(INGN) is the stronger pick with 3. 9% revenue growth year-over-year, versus 0. 5% for Lantheus Holdings, Inc. (LNTH). Lantheus Holdings, Inc. (LNTH) offers the better valuation at 25. 3x trailing P/E (16. 6x forward), making it the more compelling value choice. Analysts rate Inogen, Inc. (INGN) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — INGN or LNTH?
Over the past 5 years, Lantheus Holdings, Inc.
(LNTH) delivered a total return of +290. 0%, compared to -89. 2% for Inogen, Inc. (INGN). Over 10 years, the gap is even starker: LNTH returned +40. 0% versus INGN's -85. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — INGN or LNTH?
By beta (market sensitivity over 5 years), Lantheus Holdings, Inc.
(LNTH) is the lower-risk stock at 0. 47β versus Inogen, Inc. 's 1. 10β — meaning INGN is approximately 135% more volatile than LNTH relative to the S&P 500. On balance sheet safety, Lantheus Holdings, Inc. (LNTH) carries a lower debt/equity ratio of 0% versus 9% for Inogen, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — INGN or LNTH?
By revenue growth (latest reported year), Inogen, Inc.
(INGN) is pulling ahead at 3. 9% versus 0. 5% for Lantheus Holdings, Inc. (LNTH). On earnings-per-share growth, the picture is similar: Inogen, Inc. grew EPS 44. 1% year-over-year, compared to -21. 8% for Lantheus Holdings, Inc.. Over a 3-year CAGR, LNTH leads at 18. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — INGN or LNTH?
Lantheus Holdings, Inc.
(LNTH) is the more profitable company, earning 15. 2% net margin versus -6. 5% for Inogen, Inc. — meaning it keeps 15. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LNTH leads at 20. 2% versus -8. 7% for INGN. At the gross margin level — before operating expenses — LNTH leads at 61. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is INGN or LNTH more undervalued right now?
Analyst consensus price targets imply the most upside for INGN: 265.
7% to $26. 00.
07Which pays a better dividend — INGN or LNTH?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
08Is INGN or LNTH better for a retirement portfolio?
For long-horizon retirement investors, Lantheus Holdings, Inc.
(LNTH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 47)). Both have compounded well over 10 years (LNTH: +40. 0%, INGN: -85. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between INGN and LNTH?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.